Wireframe — structure & flow only. Visual design follows brand guidelines. All copy is placeholder pending brand voice.
Free delivery on orders over €50†
GENARIS
UK · EN2
Our story
Built by people who wanted better answers.
Genaris started in 2022 when our co-founders, a clinical researcher and a product engineer, went looking for a CBD brand that could answer a simple question: what's actually in this bottle?
No one could give a straight answer. So they built one — full ingredient disclosure, third-party testing on every batch, and a certificate anyone could open in two taps.
Meet the team →
Founder portrait
From lab notebook to product line
The first formulation took fourteen months and eleven lab-tested revisions before it met our own bar for potency consistency batch to batch. We still hold every new formula to that standard today — if it can't be verified, it doesn't ship.
That discipline is now the foundation of six product systems, each built around a single, well-evidenced outcome rather than a long list of vague promises.
Source → Extract → Test → Publish
The same four steps behind every batch we release.
1. Source
EU-grown, traceable hemp from certified farms †
2. Extract
Cold-pressed, solvent-controlled extraction
3. Test
Independent HPLC assay, ISO 17025 † labs
4. Publish
Certificate published to every batch, no login
Testing & research partners
Independent laboratory
SGS Laboratories
Ghent University
NovaLab Analytics
Check any certificate →
The team
Team portrait
Dr. Elena Cross
Co-founder & Head of Science
Team portrait
Marcus Feld
Co-founder & CEO
Team portrait
Amara Solis
Head of Formulation
Team portrait
Tom Rydell
Quality & Compliance Lead
As seen in
The Wellness Post
Nordic Health
Formulary Weekly
CleanBeauty Daily
The Sunday Brief
GENARIS
See the evidence behind every bottle. Shop the range.
Shop all products
† Draft claim — pending Genaris confirmation and legal review.
States & overlaysNot part of the page flow — shown for review